- Home
- ALRS vs SVRA Comparison
ALRS vs SVRA Comparison
Compare ALRS & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRS
- SVRA
- Stock Information
- Founded
- ALRS 1879
- SVRA 2007
- Country
- ALRS United States
- SVRA United States
- Employees
- ALRS N/A
- SVRA N/A
- Industry
- ALRS Major Banks
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- ALRS Finance
- SVRA Health Care
- Exchange
- ALRS Nasdaq
- SVRA Nasdaq
- Market Cap
- ALRS 468.2M
- SVRA 528.3M
- IPO Year
- ALRS 2019
- SVRA N/A
- Fundamental
- Price
- ALRS $21.01
- SVRA $2.28
- Analyst Decision
- ALRS Hold
- SVRA Buy
- Analyst Count
- ALRS 5
- SVRA 7
- Target Price
- ALRS $23.20
- SVRA $7.57
- AVG Volume (30 Days)
- ALRS 88.0K
- SVRA 2.5M
- Earning Date
- ALRS 07-23-2025
- SVRA 05-13-2025
- Dividend Yield
- ALRS 3.99%
- SVRA N/A
- EPS Growth
- ALRS 118.02
- SVRA N/A
- EPS
- ALRS 1.08
- SVRA N/A
- Revenue
- ALRS $224,218,000.00
- SVRA N/A
- Revenue This Year
- ALRS $40.50
- SVRA N/A
- Revenue Next Year
- ALRS $3.54
- SVRA N/A
- P/E Ratio
- ALRS $19.39
- SVRA N/A
- Revenue Growth
- ALRS 35.73
- SVRA N/A
- 52 Week Low
- ALRS $15.78
- SVRA $1.89
- 52 Week High
- ALRS $24.41
- SVRA $5.11
- Technical
- Relative Strength Index (RSI)
- ALRS 55.57
- SVRA 36.20
- Support Level
- ALRS $20.83
- SVRA $1.89
- Resistance Level
- ALRS $21.75
- SVRA $3.18
- Average True Range (ATR)
- ALRS 0.58
- SVRA 0.21
- MACD
- ALRS -0.21
- SVRA -0.11
- Stochastic Oscillator
- ALRS 23.23
- SVRA 29.77
About ALRS Alerus Financial Corporation
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.